Contact Us

Enbrel
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Medical problems since taking Enbrel:




Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Enbrel

Legionella, Listeria Infections Added to Black Box Warning for TNFa Blockers

Sep 8, 2011
| Parker Waichman LLP
Patients treated with Remicade, Enbrel, Humira, Cimzia and Simponi are at an increased risk of developing Listeria or Legionella infections. ...

FDA Releases More Humira, Enbrel, Remicade Info

Sep 1, 2009
| Parker Waichman LLP
Federal regulators have released  more information regarding cancers associated with drugs like Humira, Enbrel, and Remicade.  Last month,...

Group Calls For Study Of Arthritis Drugs

Jul 1, 2009
| Parker Waichman LLP
Arthritis and other autoimmune medications have made recent headlines over a variety of issues including links to serious opportunistic fungal...

Simponi Carries Risk of Possibly Fatal Fungal Infections

May 29, 2009
| Parker Waichman LLP
Simponi, a new rheumatoid arthritis drug, can cause severe and potentially fatal fungal infections, according to a new warning released yesterday by...

Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection Warnings

Sep 4, 2008
| Parker Waichman LLP
Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal...

Despite Enbrel Risks, FDA Panel Recommends it for Psoriasis in Children

Jun 19, 2008
| Parker Waichman LLP
A Food & Drug Administration (FDA) advisory panel has recommended that the agency approve Enbrel to treat moderate-to-severe psoriasis in...

Enbrel Infection Risk Cited

Jun 16, 2008
| Parker Waichman LLP
Enbrel has been linked to sometimes deadly infections when administered to children, casting doubts that the Food & Drug Administration (FDA)...

Humira, Enbrel, Remicade Being Investigated for Cancer Link

Jun 4, 2008
| Parker Waichman LLP
Humira and other drugs used to treat autoimmune disorders are being investigated by federal regulators amid concern that they might be linked to...

Enbrel Black Box Warns of Tuberculosis Risk

May 1, 2008
| Parker Waichman LLP
Enbrel, a drug used to treat psoriasis that has been associated with serious infections, including tuberculosis in some patients.  Enbrel's...

More Trouble for Amgen, as Enbrel Gets Stronger Infection Warnings

Mar 18, 2008
| Parker Waichman LLP
Enbrel, a popular treatment for rheumatoid arthritis and psoriasis, is getting stronger warnings about serious infections associated with its...

Page 1/2 [first] [prev] 1 2 [next] [last]